Similar articles

• Heymann nephritis: a model of human membranous glomerulopathy. A study of the role of additional antigens.

  van Leer EH, Ronco P, Verroust P, de Roo GM, Hoedemaeker PJ, de Heer E. van Leer EH, et al. Nephrol Dial Transplant. 1992;7 Suppl 1:1-8. Nephrol Dial Transplant. 1992. PMID: 1362800 Review. No abstract available.
• Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology.

  Ronco P, Allegri L, Brianti E, Chatelet F, Van Leer EH, Verroust P. Ronco P, et al. Appl Pathol. 1989;7(2):85-98. Appl Pathol. 1989. PMID: 2567175 Review.
• Synergistic effects of anti-gp330 and anti-dipeptidyl peptidase type IV antibodies in the induction of glomerular damage.

  van Leer EH, de Roo GM, Bruijn JA, Hoedemaeker PJ, de Heer E. van Leer EH, et al. Exp Nephrol. 1993 Sep-Oct;1(5):292-300. Exp Nephrol. 1993. PMID: 7915960
• Involvement of an antigen distinct from the Heymann antigen in membranous glomerulonephritis in the mouse.

  Assmann KJ, Ronco P, Tangelder MM, Lange WP, Verroust P, Koene RA. Assmann KJ, et al. Lab Invest. 1989 Jan;60(1):138-46. Lab Invest. 1989. PMID: 2642986
• Molecular aspects of immune deposit formation in Heymann nephritis.

  Kerjaschki D. Kerjaschki D. Nephrol Dial Transplant. 1992;7 Suppl 1:16-20. Nephrol Dial Transplant. 1992. PMID: 1283449 Review. No abstract available.